Group 1 - The company held its 15th meeting of the 10th Board of Directors on August 22, 2025, with all 9 directors present, including 3 independent directors [2][4] - The Board decided not to lower the conversion price of the "Kehua Convertible Bonds" for the next six months, from August 23, 2025, to February 22, 2026, despite triggering the downward adjustment clause [3][15] - The decision was made based on the company's confidence in its long-term stable development and intrinsic value, considering various factors such as stock price trends and market conditions [15] Group 2 - The "Kehua Convertible Bonds" were issued on July 28, 2020, with a total of 7.38 million bonds at a face value of 100 yuan each, amounting to a total issuance of 738 million yuan [9] - The initial conversion price was set at 21.50 yuan per share, which has undergone several adjustments due to various corporate actions, with the latest adjustment bringing it to 20.64 yuan per share effective from May 10, 2023 [10][12] - The downward adjustment clause allows the Board to propose a reduction in the conversion price if the stock price falls below 90% of the conversion price for at least 10 out of 20 consecutive trading days [13]
上海科华生物工程股份有限公司 第十届董事会第十五次会议决议公告